Skip to main content
. 2019 Dec 29;9(12):e033353. doi: 10.1136/bmjopen-2019-033353

Table 1.

Medical problems and number of mentions (total and by diagnostic group)

Medical problems NF1 PSC PAH MFS Total N
Aspects related to specific diagnoses
 Tumours 7 7
 Problems of the respiratory system 6 6
 Thrombosis 4 4
 Epilepsy 3 3
 Aneurysms 2 2
 Coeliac disease 2 2
 Itching 2 2
 Cholestasis 2 2
 Incontinence 2 2
 Low body weight 1 1
 Restriction of renal function 1 1
 Endocarditis 1 1
 Iron deficiency 1 1
 Neurological disturbances of the sensitivity 1 1
 Brief reactive psychosis 1 1
Shared aspects named by two diagnostic groups
 Fatigue 3 5 8
 Hormonal abnormalities 5 3 8
 Disfigurement 4 2 6
 Neurological disturbances of the motor function 4 1 5
 Damages from surgery 1 3 4
 Skin problems 1 2 3
Shared aspects named by three diagnostic groups
 Diarrhoea 1 9 1 11
 Limited eyesight 2 1 5 8
 Pain 1 1 3 5
 Side effects of medication 1 1 1 3

Numbers represent the total number of mentions and are displayed for each diagnosis individually as well as across all diagnostic groups; grey cells represent categories, which were mentioned at least once in a diagnostic group.

MFS, Marfan syndrome; NF1, neurofibromatosis type 1; PAH, pulmonary arterial hypertension; PSC, primary sclerosing cholangitis.